Most of the 12-14 years it takes to develop a new drug aren’t spent actually developing the drug.

Enrollment, overseeing the trial, closing the trial, submitting to regulatory bodies — that’s where the time goes.

There’s a better way — and the expedited COVID vaccines prove it.

Today, Jay Kaminski, Independent Biotech Executive and former leader of Global Clinical Research and Development Operations, joins the show to discuss how drug development can benefit from the lessons learned in other industries and turn the COVID vaccine timeline into the new standard.

In this episode, we discuss:

- Why the technology and innovation in clinical trials lags behind the science

- How other industries, such as mobile banking, can shape faster, more effective drug development

- Why standardization and partnerships would radically transform the effectiveness of the industry

To hear more from Accelerating Clinical, check us out on Apple Podcasts, Spotify, or on our website.

Listening on a desktop & can’t see the links? Just search for Accelerating Clinical on your favorite podcast player.